Here are relevant reports on : human-augmentation-market
-
AI Avatar Market by Platform (Digital Human, 3D & Metaverse Avatars, Stylized Avatars), Type (Interactive Avatars, Noninteractive Avatars), Application (Virtual Assistant, Characters, Influencer, Companion, Podcaster & VTuber) - Global Forecast to 2032
The AI avatar market is expanding rapidly, with a projected market size anticipated to rise from USD 0.80 billion in 2025 to USD 5.93 billion by 2032, featuring a CAGR of 33.1%. The major players in the AI avatar market include Synthesia (UK), HeyGen (US), D-ID (Israel), Akool (US), Veritone (US), NVIDIA (US), AWS (US), Meta (US), Vyond (US), and Soul Machines (US).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026
The global artificial cornea and corneal implant market in terms of revenue was estimated to be worth $418 million in 2021 and is poised to reach $599 million by 2026, growing at a CAGR of 7.4% from 2021 to 2026. Some of the major players operating in the market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Cloud ERP Market by Software (Full Suite, Modules), Application (Financial Management, Project Management, Human Resources Management, Supply Chain Management, Inventory Management, Other Applications), Vertical - Global Forecast to 2029
The cloud ERP market is projected to reach USD 172.74 billion by 2029 at a CAGR of 14.5% during the forecast period. Some of the cloud ERP vendors are SAP (Germany), Oracle (US), Microsoft (US), Intuit (US), Infor (US), Epicor (US), Sage Group (US), IFS (Sweden), Plex (US) and Acumatica (US).
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Human Capital Management Market by Software (Core HR, Workforce Management, HR Analytics, and Applicant Tracking System), Services (Professional Services and Managed Services), Deployment Model, Organization Size - Global Forecast to 2029
The Human Capital Management market size is projected to reach USD 41.3 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period. Some of the key players operating in the HCM market are – Workday (US), UKG (US), Oracle (US), SAP (Germany), Dayforce (US), ADP (US), Paylocity (US), Paycom (US), Cornerstone (US), and Microsoft (US).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Swarm Intelligence Market by Model, Capability (Clustering, Routing, Scheduling, and Optimization), Application (Robotics, Drones, and Human Swarming), and Geography - Global Forecast to 2030
The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The estimated year considered for the study is 2020, and the forecast period is between 2020 and 2023. The report profiles the most promising players in this market. The key players in this market are DoBots (Netherlands), Hydromea (Switzerland), Sentien Robotics (US), Unanimous A.I. (US), AxonAI (US), Swarm Technology (US), SSI Schäfer - Fritz Schäfer (Germany), Valutico (Austria), Enswarm (UK), and Power-Blox (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Choline Chloride Market by End-User (Poultry feed, Swine feed, Ruminant feed, Aqua feed & others, Human nutrition and Oil & Gas, and Misc. applications), and Geography - Regional Trends & Forecast to 2019
Choline chloride is an organic compound. It is used in the animal feed additive. It is mainly related with the metabolism and act as methyl donor. It builds and maintains cell structure and function. It is very essential for growing animal and its feed intake helps in preventing perosis, conditions like fatty liver syndrome, etc. Apart from animal feed additive, it is also used in human nutrition and as a clay stabilizer in oil and gas industry.
- Published: April 2014
- Price: $ 4950
- TOC Available:
-
Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The Europe probiotics market is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030. The key players include Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
